Abstract
Objective
Compare the effectiveness of 2 supplementary foods, ready-touse therapeutic food (RUTF) and corn/ soy blend (CSB), given to wasted patients beginning the standard ART protocol, in improving the nutritional and clinical outcomes after 3.5 months.
Site
QECH adult ARV clinic
Methods
490 wasted (Body mass index, BMI < 18.5) adults starting ART were randomized to receive isoenergetic amounts of RUTF or CSB as dry rations. Weight, fat free body mass measured by bioelectrical impedance, CD4 count measured by FACS count machine and significant clinical events (hospitalizations + deaths) were measured at the monthly visits. The primary outcomes were BMI and fat free body mass, and the secondary outcomes were CD4 count and significant clinical events. Outcomes were compared with a Student's t-test for continuous parameters and with a Chi-Square test for dichotomous outcomes.
Results
On enrollment subjects had a mean BMI of 16.5 and fat free body mass of 95. After 3.5 months of therapy patients receiving RUTF (n=161) had a weight gain 5.7 ±4.6 kg and BMI gain 2.2 ±1.8, compared to patients receiving CSB with weight gain of 4.5±4.2kg and BMI gain of 1.7±1.6. There were significant improvements in the weight gain, BMI, Fat-Free Mass and the CD4 cell count at 3.5 months of study participation in patients of both supplementary food groups. However, the increase in weight, BMI and the CD4 cell count of patients in the RUTF supplementary food group, were statistically significantly higher than in patients of the CSB supplementary food group, 5.7 (±4.6), vs 4.5 (±4.2) kg, 2.2 (±1.8) vs 1.7 (±1.6) and 165 (±137) vs 155 (±142) cells × 106/L, respectively, (p <0.05). Of the study participants who have completed the 3.5 months of nutritional intervention, less deaths occurred in patients of the RUTF than in the CSB supplementary feeding group, 17.1% vs. 20.0%. Less drop- outs occurred in patients of the RUTF than in the CSB supplementary feeding group, 7.3% vs. 8.5%, respectively.
Conclusion
Supplementary feeding with specially formulated RUTF, was associated with more increase in weight, BMI and CD4 cell count, but there were no differences in the survival of the wasted HIV-infected patients on ART Program.
